|
KIF15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.60000959335139E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.799500E-04 |
| Normal-vs-Stage2 |
4.105600E-02 |
| Normal-vs-Stage3 |
1.010770E-04 |
| Normal-vs-Stage4 |
2.984200E-02 |
| Stage1-vs-Stage2 |
5.873600E-01 |
| Stage1-vs-Stage3 |
1.298060E-03 |
| Stage1-vs-Stage4 |
1.979900E-02 |
| Stage2-vs-Stage3 |
7.215700E-02 |
| Stage2-vs-Stage4 |
1.275630E-01 |
| Stage3-vs-Stage4 |
8.705400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.04339999973391E-08 |
| Normal-vs-AfricanAmerican |
2.371800E-04 |
| Normal-vs-Asian |
6.005700E-02 |
| Caucasian-vs-AfricanAmerican |
2.655600E-01 |
| Caucasian-vs-Asian |
2.888800E-01 |
| AfricanAmerican-vs-Asian |
4.171900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75259995405241E-09 |
| Normal-vs-Female |
5.56789999999197E-05 |
| Male-vs-Female |
2.738400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.596000E-04 |
| Normal-vs-Extreme_Weight |
3.99299999997993E-06 |
| Normal-vs-Obese |
1.58849999999378E-05 |
| Normal-vs-Extreme_Obese |
2.013600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.770300E-02 |
| Normal_Weight-vs-Obese |
9.389600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.372250E-02 |
| Extreme_Weight-vs-Obese |
2.500300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.157170E-01 |
| Obese-vs-Extreme_Obese |
2.496700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.857620E-03 |
| Normal-vs-Age(41-60Yrs) |
7.40549999100892E-09 |
| Normal-vs-Age(61-80Yrs) |
3.003500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.161600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.401600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.660100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.252030E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.010200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.999900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.519800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.51449996566822E-09 |
| Normal-VS-Type2 PRCC |
8.20100000000767E-05 |
| Normal-VS-KIRP CIMP |
8.843600E-04 |
| Normal-VS-Unclassified PRCC |
1.842030E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.025600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.861990E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.210100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.943400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.340000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.744500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.411600E-04 |
| Normal-vs-N1 |
1.93639999999107E-05 |
| Normal-vs-N2 |
1.262980E-01 |
| N0-vs-N1 |
7.017600E-04 |
| N0-vs-N2 |
1.161960E-01 |
| N1-vs-N2 |
4.584400E-01 |
|
|
